rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1997-3-25
|
pubmed:abstractText |
The small GTPase R-Ras displays a less potent transforming activity than the closely related Ras oncogene products. Although R-Ras has been reported to interact with c-Raf1 and Ral-GDS in vitro, the pathways by which it exerts its effects on cellular proliferation are not known.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0960-9822
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
63-70
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8999998-Animals,
pubmed-meshheading:8999998-Calcium-Calmodulin-Dependent Protein Kinases,
pubmed-meshheading:8999998-Cell Transformation, Neoplastic,
pubmed-meshheading:8999998-Enzyme Activation,
pubmed-meshheading:8999998-GTP Phosphohydrolases,
pubmed-meshheading:8999998-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:8999998-Mice,
pubmed-meshheading:8999998-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:8999998-Phosphotransferases (Alcohol Group Acceptor),
pubmed-meshheading:8999998-ras Proteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways.
|
pubmed:affiliation |
Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|